News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sapphire Therapeutics, Inc. Appoints New Director And Scientific Advisory Board



1/17/2006 11:08:55 AM

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Jan. 17, 2006--Sapphire Therapeutics, Inc., a private biopharmaceutical company focused on cancer and metabolic disorders, today announced the addition of a new director and the appointment of a scientific advisory board (SAB). These appointments, along with recent management hires and promotions, are part of a controlled growth strategy to support two drugs in clinical development, advance the company's preclinical pipeline and in-license additional drug candidates.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES